135 related articles for article (PubMed ID: 32389520)
1. Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients.
Grinnell M; Appiah AK; Baine M; Ernani V; Marr A; Zhang C; Zhen W; Buddharaju LNR; Smith LM; Ganti AK
J Geriatr Oncol; 2020 Sep; 11(7):1145-1153. PubMed ID: 32389520
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
[TBL] [Abstract][Full Text] [Related]
3. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
7. Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm.
Tran JH; Mhango G; Park HS; Marshall DC; Rosenzweig KE; Wang Q; Wisnivesky JP; Veluswamy RR
Clin Lung Cancer; 2023 Jan; 24(1):e9-e18. PubMed ID: 36443153
[TBL] [Abstract][Full Text] [Related]
8. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
10. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer.
Amin SA; Alam M; Baine MJ; Meza JL; Bennion NR; Zhang C; Rahman I; Lin C
Radiother Oncol; 2021 Feb; 155():254-260. PubMed ID: 33317997
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
Baine MJ; Sleightholm R; Neilsen BK; Oupický D; Smith LM; Verma V; Lin C
J Natl Compr Canc Netw; 2019 May; 17(5):450-458. PubMed ID: 31085762
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer.
Verma V; McMillan MT; Grover S; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):146-154. PubMed ID: 27843029
[TBL] [Abstract][Full Text] [Related]
15. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer.
Yan SX; Qureshi MM; Dyer M; Truong MT; Mak KS
Lung Cancer; 2019 May; 131():147-153. PubMed ID: 31027693
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
19. Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer.
Duvergé L; Bondiau PY; Claude L; Supiot S; Vaugier L; Thillays F; Doyen J; Ricordel C; Léna H; Bellec J; Chajon E; de Crevoisier R; Castelli J
Lung Cancer; 2021 Jul; 157():100-108. PubMed ID: 34016489
[TBL] [Abstract][Full Text] [Related]
20. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]